GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sonoma Pharmaceuticals Inc (STU:O8Z3) » Definitions » Cyclically Adjusted PB Ratio

Sonoma Pharmaceuticals (STU:O8Z3) Cyclically Adjusted PB Ratio : 0.01 (As of Jun. 19, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Sonoma Pharmaceuticals Cyclically Adjusted PB Ratio?

As of today (2024-06-19), Sonoma Pharmaceuticals's current share price is €0.1706. Sonoma Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €21.11. Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio for today is 0.01.

The historical rank and industry rank for Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:O8Z3' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.23   Max: 1.41
Current: 0.01

During the past years, Sonoma Pharmaceuticals's highest Cyclically Adjusted PB Ratio was 1.41. The lowest was 0.01. And the median was 0.23.

STU:O8Z3's Cyclically Adjusted PB Ratio is ranked better than
99.87% of 752 companies
in the Drug Manufacturers industry
Industry Median: 1.84 vs STU:O8Z3: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sonoma Pharmaceuticals's adjusted book value per share data for the three months ended in Dec. 2023 was €0.448. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €21.11 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sonoma Pharmaceuticals Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sonoma Pharmaceuticals Cyclically Adjusted PB Ratio Chart

Sonoma Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.26 0.18 0.33 0.16 0.04

Sonoma Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.03 0.01

Competitive Comparison of Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio falls into.



Sonoma Pharmaceuticals Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=0.1706/21.11
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonoma Pharmaceuticals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Sonoma Pharmaceuticals's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.448/129.4194*129.4194
=0.448

Current CPI (Dec. 2023) = 129.4194.

Sonoma Pharmaceuticals Quarterly Data

Book Value per Share CPI Adj_Book
201403 48.097 99.695 62.438
201406 52.473 100.560 67.532
201409 54.379 100.428 70.077
201412 32.989 99.070 43.095
201503 33.314 99.621 43.279
201506 28.475 100.684 36.602
201509 26.251 100.392 33.841
201512 21.719 99.792 28.167
201603 19.527 100.470 25.153
201606 14.779 101.688 18.809
201609 11.514 101.861 14.629
201612 45.815 101.863 58.209
201703 42.045 102.862 52.900
201706 34.602 103.349 43.331
201709 28.221 104.136 35.073
201712 23.378 104.011 29.089
201803 18.125 105.290 22.279
201806 15.124 106.317 18.410
201809 12.838 106.507 15.600
201812 8.815 105.998 10.763
201903 7.052 107.251 8.510
201906 7.729 108.070 9.256
201909 7.013 108.329 8.378
201912 5.675 108.420 6.774
202003 2.864 108.902 3.404
202006 5.151 108.767 6.129
202009 4.808 109.815 5.666
202012 4.870 109.897 5.735
202103 2.153 111.754 2.493
202106 1.832 114.631 2.068
202109 3.242 115.734 3.625
202112 3.189 117.630 3.509
202203 2.547 121.301 2.717
202206 2.428 125.017 2.514
202209 2.285 125.227 2.362
202212 1.688 125.222 1.745
202303 1.510 127.348 1.535
202306 1.300 128.729 1.307
202309 1.027 129.860 1.024
202312 0.448 129.419 0.448

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sonoma Pharmaceuticals  (STU:O8Z3) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Sonoma Pharmaceuticals Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Sonoma Pharmaceuticals's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sonoma Pharmaceuticals (STU:O8Z3) Business Description

Traded in Other Exchanges
Address
5445 Conestoga Court, Suite 150, Boulder, CO, USA, 80301
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, and other countries.

Sonoma Pharmaceuticals (STU:O8Z3) Headlines

No Headlines